The Federation of American Societies for Experimental Biology (FASEB), the United States’ largest coalition of biological and biomedical research associations, calls on Congress to approve the bipartisan budget deal announced on October 26. Passage of the deal will enable progress on stalled legislation to increase federal research funding.
“We are pleased that the congressional leadership and President Obama were able to reach consensus on a path forward,” said Parker B. Antin, PhD, FASEB President. “After years in which research funding did not keep pace with rising costs, increasing funding for research is vital to maintaining the United States' historic global leadership in science and technology and to developing new treatments for the diseases and disorders affecting our families and communities. This agreement will allow proposed increases for the National Institutes of Health and the National Science Foundation to become a reality.”
Earlier this year, the House and Senate Appropriations Committees approved preliminary legislation to raise the federal investment in biological and biomedical research. However, these bills have been caught up in a protracted dispute over spending levels and priorities.
In September, FASEB and the presidents of 21 of its member societies sent a letter urging lawmakers to pass a bipartisan budget deal that includes increased funding for scientific research. In addition, an e-action alert issued by FASEB generated more than 9,100 emails to all 100 senators and the majority of House members urging that action be taken on the budget.